Skip to main content
. 2024 Nov 8;13(21):e70319. doi: 10.1002/cam4.70319

TABLE 2.

Cox‐regression uni‐variate analysis for ARAT‐failure survival.

Univariate analysis Multi‐variate analysis
B SE Wald df p Exp (B) p Exp (B)
General parameters
Age 0.013 0.006 4.454 1.000 0.035* 1.013 0.021* 1.020
BMI −0.033 0.017 3.890 1.000 0.049* 0.968 0.152 0.974
ECOG −1.056 0.589 3.223 1.000 0.002** 0.348 0.471
ISUP Group 0.154 0.055 7.787 1.000 0.005** 1.166 0.001** 1.223
DeNovo Mets 0.172 0.143 1.434 1.000 0.231 1.187
1st ARAT agent 0.278 0.117 5.619 1.000 0.018* 1.321 0.386 1.128
Chemotherapy Naïve −0.586 0.131 20.137 1.000 < 0.0001** 0.556 < 0.0001** 0.407
Duration from HSPC to CRPC 0.000 0.000 1.300 1.000 0.254 1.000
Serum markers
iPSA 0.000 0.000 0.725 1.000 0.395 1.000
Nadir PSA during ADT 0.003 0.001 8.444 1.000 0.004** 1.003 0.421 1.001
PSA when starting ARAT 0.000 0.000 3.504 1.000 0.061 1.000

Abbreviations: ADT = androgen deprivation therapy; ARAT = androgen receptor‐axis‐targeted therapies; BMI = Body Mass Index; ECOG = Eastern Cooperative Oncology Group; ISUP = International Society of Urological Pathology; PSA = prostate‐specific antigen.

*

p < 0.05.

**

p < 0.01.